Latest Articles
5 Top Hysterectomy Surgery Myths to Stop Believing - Right as Rain by UW Medicine
5 Top Hysterectomy Surgery Myths to Stop Believing Right as Rain by UW Medicine
Published: April 4, 2025, noon
SGO 2025: Impact of Precision Medicine in Endometrial Cancer - Medscape
SGO 2025: Impact of Precision Medicine in Endometrial Cancer Medscape
Published: April 3, 2025, 5:21 p.m.
Human-Specific Model of Endometriosis Shows Promise for Personalized Treatments - Physicians Committee for Responsible Medicine
Human-Specific Model of Endometriosis Shows Promise for Personalized Treatments Physicians Committee for Responsible Medicine
Published: March 28, 2025, 9:47 p.m.
Ferroptosis in Endometriosis: Traditional Chinese Medicine Interventions and Mechanistic Insights.
Endometriosis (EMS) is a chronic, estrogen-dependent inflammatory disease affecting 5-10% of women of reproductive age, characterized by the growth of endometrial tissue on the outside of the uterus. The dysregulation …
Published: March 27, 2025, midnight
Endometriosis and the lesser-known thoracic endometriosis syndrome - Baylor College of Medicine | BCM
Endometriosis and the lesser-known thoracic endometriosis syndrome Baylor College of Medicine | BCM
Published: March 26, 2025, 12:55 p.m.
Endometriosis: assessment on O-RADS and risk of malignant transformation.
Endometriosis is a common disease, affecting approximately 10% of women of reproductive age. Several intersecting guidelines and consensus statements provide information on imaging diagnosis and surveillance strategies for endometriomas. SRU …
Published: March 26, 2025, midnight
Cheap medicine, free GP visits under $124.8b healthcare budget - MSN
Cheap medicine, free GP visits under $124.8b healthcare budget MSN
Published: March 25, 2025, 9:41 a.m.
Cheaper medicine, free GP visits and less hospital waiting time under $124.8b healthcare plan - 9News
Cheaper medicine, free GP visits and less hospital waiting time under $124.8b healthcare plan 9News
Published: March 25, 2025, 8:36 a.m.
Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer - 2 Minute Medicine
Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer 2 Minute Medicine
Published: March 17, 2025, 11:07 p.m.
Helpful strategies to put an end to endometriosis - Baylor College of Medicine | BCM
Helpful strategies to put an end to endometriosis Baylor College of Medicine | BCM
Published: March 17, 2025, 12:50 p.m.
Link copied to clipboard!